BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Chiome Bioscience Inc.

Headquarters: Tokyo, Japan
Year Founded: 2005
Status: Public
Industry Sector: HealthTechnology
CEO: Shigeru Kobayashi
Number Of Employees: N/A
Enterprise Value: $88,866,007
PE Ratio: -8.67
Exchange/Ticker 1: Tokyo:4583
Exchange/Ticker 2: N/A
Latest Market Cap: $69,274,613

BioCentury | Sep 15, 2020
Product Development

Data Bytes: Trodelvy leads TROP2 pack

BioCentury | Apr 11, 2016
Company News

Chiome, ADC Therapeutics deal

BioCentury | Aug 3, 2015
Company News

Chiome, ADC Therapeutics deal

BioCentury | Apr 6, 2015
Finance

Up, up and acquired

Winners, losers in biotech stock tiers in 1Q15
BioCentury | Feb 23, 2015
Finance

Daiwa dives in

How Daiwa plans to invest first biotech fund in Japan, Taiwan
BioCentury | Mar 24, 2014
Company News

Chiome antibodies news

BioCentury | Mar 24, 2014
Finance

Highlights of weekly biotech stock moves

Regulatory, clinical and other milestones
BioCentury | Feb 10, 2014
Finance

A Japanese correction

Japanese biotechs see large correction but still up since January 2013
BioCentury | Jul 1, 2013
Company News

Chiome antibodies news

Items per page:
1 - 10 of 35